Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy
Cancer Growth and Metastasis · 2013
DOI: 10.4137/cgm.s11134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Growth and Metastasis, 2013. Verfasst von Liang Schweizer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lead Evaluation and Mechanistic Biochemistry, Bristol Myers Squibb Company, Princeton, NJ. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The link between signaling pathways and diseases suggests the importance of pathway analysis for drug discovery. This includes target identification and validation, compound mode of action and drug candidate optimization. Here, we propose to apply cell signaling pathway panel approaches for oncology drug discovery. The strategies and guiding principles of the pathway panel approach are discussed. 2 pathway analysis examples with related processes and technology platforms are illustrated to identify cancer drugs that target cancer growth and metastasis. Finally, we highlight potential challenges and opportunities presented by the pathway panel approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lead Evaluation and Mechanistic Biochemistry, Bristol Myers Squibb Company, Princeton, NJ.
Zitieren
APA
Schweizer, L., & Zhang, L. (2013). Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy. Cancer Growth and Metastasis. https://doi.org/10.4137/cgm.s11134
Vancouver
Schweizer L, Zhang L. Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy. Cancer Growth and Metastasis. 2013. doi:10.4137/cgm.s11134
BibTeX
@article{Schweizer2013,
author = {Schweizer, Liang and Zhang, Litao},
title = {Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy},
journal = {Cancer Growth and Metastasis},
year = {2013},
doi = {10.4137/cgm.s11134}
}
EUVIMED